CTOR — Citius Oncology Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Annual balance sheet for Citius Oncology, fiscal year end - September 30th, USD millions except per share, conversion factor applied.

	2022 September 30th	2023 September 30th	2024 September 30th
Period Length:	—	—	—
Source:	PROSPECTUS	PROSPECTUS	10-K
Standards:	USG	USG	USG
Status:	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	0	0	0
Total Inventory
Prepaid Expenses
Total Current Assets	2.69	7.73	11
Net Intangible Assets
Total Assets	42.7	47.7	84.4
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	5.85	21	32.7
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	6.42	22.2	38.2
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	36.3	25.5	46.1
Total Liabilities & Shareholders' Equity	42.7	47.7	84.4
Total Common Shares Outstanding